Advertisement
Advertisement
U.S. markets close in 4 hours 53 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
25.07+1.29 (+5.42%)
As of 11:06AM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/29/2022
Current
3/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
2.59B2.39B2.10B2.27B2.55B
Enterprise Value
2.25B2.17B1.74B1.90B2.18B
Trailing P/E
26.7925.3023.8625.8928.21
Forward P/E
21.8824.1019.4220.0829.33
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
7.847.757.137.288.15
Price/Book (mrq)
6.356.373.884.344.99
Enterprise Value/Revenue
5.9123.1517.5819.7723.77
Enterprise Value/EBITDA
16.6878.6746.3851.3766.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 36.59%
S&P500 52-Week Change 3-13.03%
52 Week High 325.68
52 Week Low 315.83
50-Day Moving Average 321.20
200-Day Moving Average 321.06

Share Statistics

Avg Vol (3 month) 3883.42k
Avg Vol (10 day) 3783.31k
Shares Outstanding 5106.25M
Implied Shares Outstanding 6N/A
Float 886.7M
% Held by Insiders 110.92%
% Held by Institutions 177.89%
Shares Short (May 30, 2022) 419.24M
Short Ratio (May 30, 2022) 419.67
Short % of Float (May 30, 2022) 428.09%
Short % of Shares Outstanding (May 30, 2022) 418.11%
Shares Short (prior month Apr 28, 2022) 418.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 29.41%
Operating Margin (ttm)34.61%

Management Effectiveness

Return on Assets (ttm)16.12%
Return on Equity (ttm)24.35%

Income Statement

Revenue (ttm)380.23M
Revenue Per Share (ttm)3.37
Quarterly Revenue Growth (yoy)17.90%
Gross Profit (ttm)360.7M
EBITDA 132.71M
Net Income Avi to Common (ttm)111.84M
Diluted EPS (ttm)0.91
Quarterly Earnings Growth (yoy)-2.80%

Balance Sheet

Total Cash (mrq)345.53M
Total Cash Per Share (mrq)3.25
Total Debt (mrq)2.82M
Total Debt/Equity (mrq)0.69
Current Ratio (mrq)6.78
Book Value Per Share (mrq)3.84

Cash Flow Statement

Operating Cash Flow (ttm)177.72M
Levered Free Cash Flow (ttm)139.04M
Advertisement
Advertisement